期刊文献+

急性心肌梗死患者血清代谢物谱的筛选研究 被引量:6

Investigation of serum metabolic profiling in acute myocardium infarction
原文传递
导出
摘要 目的 分析急性心肌梗死(AMI)患者血清代谢轮廓,寻找早期诊断急性心肌梗死的代谢指标.方法 病例对照研究.收集2011年5月至2012年3月天津市第三中心医院住院确诊的AMI患者42例及同期体检的健康成人35名采用超高效液相色谱与质谱联用(UPLC-MS)代谢组学研究平台筛选特征代谢物,利用SPSS17.0软件进行统计分析,同时利用ROC曲线对特征代谢物的临床诊断效能进行评估.结果 构建了“急性心肌梗死患者-健康对照组”的主成分分析(R2X=75.6%,Q2 =39.7%)及正交偏最小二乘代谢轮廓分析模型(R2Y=97.8%,Q2=97.0%)并鉴定了19个差异代谢物,其中甘油磷脂类物质在AMI患者血清中均呈下调趋势,而鞘磷脂类物质大部分均呈上调趋势,鉴定出的代谢物的曲线下面积均大于0.8,验证结果模型的预测准确度达到100%.结论 利用代谢轮廓分析方法所找到的特征代谢物具有很好的区分AMI患者与健康人群的能力,可以作为潜在的疾病诊断标志物及新治疗靶点在临床领域做进一步研究. Objective To evaluate the serum metabolic profiling of acute myocardium infarction (AMI) patients,establish a disease distinguishing model and to select characteristic metabolites with potential clinical diagnostic value.Methods All 42 AMI patients and contemporaneous 35 healthy physical examination adults from May 2011 to March 2012 at the Third Central Hospital of Tianjin.UPLC-LTQ Orbitrap XL MS platform filter characteristics of metabolites.SPSS 17.0 was used for statistical analysis.ROC curve was established to assess the clinical diagnostic value of selected characteristic metabolites.Results PCA (R2X =75.6%,Q2 =39.7%) model and OPLS-DA (R2Y =97.8%,Q2 =97.0%) model were established and 19 ions were identified.Glycerophospholipids decreased in AMI group and sphingophospholipids increased in AMI group.The areas under the curve of all identified metabolites were greater than 0.8.Conclusion Metabolites selected in metabolic profiling analysis show outstanding ability in distinguishing AMI from health people and can be used as potential diagnostic biomarkers and benefit in further clinical study as novel drug targets
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2013年第11期1022-1026,共5页 Chinese Journal of Laboratory Medicine
关键词 心肌梗死 代谢组学 色谱法 高压液相 质谱分析法 Myocardial infarction Metabolomics Chromatography, high pressure liquid Mass spectrometry
  • 相关文献

参考文献13

  • 1Lewis GD,Asnani A,Gerszten RE.Application of metabolomics to cardiovascular biomarker and pathway discovery.J Am Coll Cardiol,2008,52:117-123.
  • 2Ott KH,Araníbar N,Singh B,et al.Metabonomics classifies pathways affected by bioactive compounds.Artificial neural network classification of NMR spectra of plant extracts.Phytochemistry,2003,62:971-985.
  • 3Katajamaa M,Oresic M.Processing methods for differential analysis of LC/MS profile data.BMC Bioinformatics,2005,6:179.
  • 4陈静,单圆鸿,严沁,赵素敏,尹沛源,赵欣捷,路鑫,席晓薇,万小平,许国旺.一种基于液相色谱-质谱技术进行血清代谢组学研究的方法:从代谢指纹到潜在标志物[J].中国科学(B辑),2009,39(10):1268-1276. 被引量:19
  • 5Brand A,Yavin E.Translocation of ethanolamine phosphoglyceride is required for initiation of apoptotic death in OLN-93 oligodendroglial cells.Neurochem Res,2005,30:1257-1267.
  • 6陈曦.溶血磷脂酸受体及下游信号通路在心脏细胞生长中的调节作用[J].生理学报,2007,59(5):619-627. 被引量:12
  • 7Van Brocklyn JR,Williams JB.The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase:oxidative stress and the seesaw of cell survival and death.Comp Biochem Physiol B Biochem Mol Biol,2012,163:26-36.
  • 8Hagen-Euteneuer N,Lütjohann D,Park H,et al.Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons.J Biol Chem,2012,287:9128-9136.
  • 9Thielmann M,D(o)rge H,Martin C,et al.Myocardial dysfunction with coronary microembolization:signal transduction through a sequence of nitric oxide,tumor necrosis factor-alpha,and sphingosine.Circ Res,2002,90:807-813.
  • 10Kurosu M,Katayama S,Shibuya H,et al.A study of the calcium complex of a glucosylceramide,soya-cerebroside Ⅱ.Chem Pharm Bull (Tokyo),2007,55:1758-1761.

二级参考文献63

  • 1何兰杰,韩变梅,马睿,李虹伟,沈潞华,陈曦.溶血磷脂酸及其受体在大鼠心肌重塑中的作用[J].基础医学与临床,2005,25(7):615-619. 被引量:5
  • 2Nicholson J K. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol, 2006, 2: article 52.
  • 3Nicholson J K, Lindon J C, Holmes E. "Metabonomics": Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological N MR spectroscopic data. Xenobiotica, 1999, 29(11): 1181 - 1189.
  • 4Seo D, Ginsburg G. S. Genomic medicine: bringing biomarkers to clinical medicine. Curr Opin Chem Biol, 2005, 9(4): 381-386.
  • 5Yang J, Xu G W, Zheng Y F, Kong H W, Pang T, Lv S, Yang Q. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B, 2004, 813(1-2): 59-65.
  • 6De Vos R C H, Moco S, Lommen A, Keurentjes J J B, Bino R J, Hall R D. Untargeted large-scale plant metabolomics using liquid chromatography coupled to mass spectrometry. Nat Protoc, 2007, 2(4): 778-791.
  • 7Yin P Y, Zhao X J, Li Q R, Wang J S, Li J s, Xu G W. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res, 2006, 5(9): 2135 -2143.
  • 8Kind T, Tolstikov V, Fiehn O, Weiss R H. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem, 2007, 363(2): 185-195.
  • 9Chen J, Wang W Z, Lv S, Yin P Y, Zhao X J, Lu X, Zhang F X, Xu G W. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal Chim Acta, 2009, doi:10.1016/j.aca.2009.03.039.
  • 10Sreekumar A, Poisson L M, Rajendiran T M, Khan A P, Cao Q, YuJ D, Laxman B, Mehra R, Lonigro R J, Li Y, Nyati M K, Ahsan A, Kalyana-Sundaram S, Han B, Cao X H, Byun J, Omenn G S, Ghosh D, Pennathur S, Alexander D C, Berger A, Shuster J R, Wei J T, Varambally S, Beecher C, Chinnaiyan A M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 2009, 457(7231): 910-914.

共引文献29

同被引文献33

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部